You need to enable JavaScript to run this app.
Recon: FDA and Biogen’s Aduhelm back channel; FDA rejects MediWound burn treatment
Recon
Michael Mezher
Biologics/ biosimilars/ vaccines
Biotechnology
Combination products/companion diagnostics
Diagnostics/IVDs
Medical Devices
Pharmaceuticals